万亿市场火热!MNC销冠易主,诺华大涨超20%,诺和诺德、礼来“激战”

米内网
Yesterday

精彩内容近日,随着各大跨国药企2024年财报的发布,阿斯利康、默沙东等在中国区营收也浮出水面。其中,阿斯利康重返销冠宝座,诺华大涨超20%。此外,不少的跨国药企动作频繁,加速布局中国市场,阿斯利康豪掷25亿美元加码中国投资计划,辉瑞、拜耳等企业的研发创新中心纷纷落户北京,这背后蕴含着政策、市场、人才资源等多元的驱动因素。跨国药企2024中国区成绩单出炉!阿斯利康重返销冠,诺华大涨超20%近日,各大...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10